Key speakers

Hear from industry leaders, non profit and patient groups as well as government and payers at this years event 

 

  • Mr Henri Termeer at World Orphan Drug Congress
    Mr Henri Termeer
    Chief Executive Officer, Former
    Genzyme
    Rito Bergemann at World Orphan Drug Congress
    Rito Bergemann
    Director, Value Evidence Lead Rare Diseases
    GSK
  • David Jakouloff at World Orphan Drug Congress
    David Jakouloff
    Global Market Access Director of Oncology and Orphan Disease
    Takeda
    Hans Schikan at World Orphan Drug Congress
    Hans Schikan
    Former CEO
    Prosensa
  • Dr Segolene Ayme at World Orphan Drug Congress
    Dr Segolene Ayme
    Director of Research
    I.N.S.E.R.M.
    Dr Ana Mingorance-Le Meur at World Orphan Drug Congress
    Dr Ana Mingorance-Le Meur
    Scientific Director
    Dravet Syndrome Foundation
  • Mrs Debra Miller at World Orphan Drug Congress
    Mrs Debra Miller
    President and Chief Executive Officer
    CureDuchenne
    Mr Bruce Bloom at World Orphan Drug Congress
    Mr Bruce Bloom
    President and Chief Scientific Officer
    Cures Within Reach
  • Mr Francois Meyer at World Orphan Drug Congress
    Mr Francois Meyer
    Advisor To The President
    Haute Autorite De Sante
    Dr Cesar Hernandez at World Orphan Drug Congress
    Dr Cesar Hernandez
    Head of Department of Medicines for Human Use
    Spanish Agency of Medicines and Medical Devices

 

The future of rare diseases and orphan drugs

 

  • Discuss pressing issues such as the pricing and reimbursement debate, commercialisation challenges and engaging with patients during research and development of new therapies.     

  • Meet and interact with representatives from pharma, biotechs, payers, government, regulators, academia and patient groups. 

  • Use extended networking time to seek out and build partnerships to speed up the development of orphan drugs.      

DOWNLOAD BROCHURE

A GLOBAL EVENT 

We're excited to be welcoming attendees from all over the globe for this year's congress. Share, debate and engage with an international audience and take back valuable insights to your company.

 

 

 

 

 

 

 

 

 

 

 

 

 

Europe

North America

South America  

   Africa

Asia

Australia

Should you sponsor?

Why get involved?

Find out more about how you can promote your products at the orphan drug sector’s premier event by downloading the sponsorship brochure today. 

"WODC is the key annual congress for anybody working in the rare disease arena.”
Oxford PharmaGenesis

Why sponsor?

  • Speak to a room full of orphan drug experts

  • Host a roundtable and meet your customers

  • Let us organise 1-2-1 meetings for you

  • Let us generate sales leads pre-event

  • Take a private meeting room

Why exhibit?

  • Show off your latest products & innovations

  • Promote new services

  • Educate your target market

  • Generate new sales leads

  • Raise brand profile

GET THE PROSPECTUS

 

Sponsor & Exhibitors

 

  • Supporting Partner

    GlaxoSmithKline at World Orphan Drug Congress

    Gold Sponsor

    Shire Human Genetic Therapies at World Orphan Drug Congress
  • Gold Sponsor

    Premier Research at World Orphan Drug Congress

    Gold Sponsor

    Pfizer at World Orphan Drug Congress
  • Gold Sponsor

    MAPI at World Orphan Drug Congress

    Gold Sponsor

    PTC Therapeutics at World Orphan Drug Congress
  • Gold Sponsor

    Quintiles at World Orphan Drug Congress

    Gold Sponsor

    Idis Managed Access at World Orphan Drug Congress
  • Silver Sponsor

    Alliance Life Sciences at World Orphan Drug Congress

    Bronze Sponsor

    Pharma Price International at World Orphan Drug Congress
  • Bronze Sponsor

    Durbin Plc at World Orphan Drug Congress

    Bronze Sponsor

    Genpharm at World Orphan Drug Congress
  • Bronze Sponsor

    Voisin Consulting Life Sciences at World Orphan Drug Congress

    Bronze Sponsor

    Ergomed at World Orphan Drug Congress
  • Company Showcase Sponsor

    BioBlast Pharma Ltd at World Orphan Drug Congress

    Exhibitor

    University of Oxford at World Orphan Drug Congress
  • Exhibitor

    Apotek Produktion & Laboratorier AB at World Orphan Drug Congress

    Exhibitor

    Clear Pharma at World Orphan Drug Congress
  • Exhibitor

    Comradis at World Orphan Drug Congress

    Exhibitor

    Cote Orphan at World Orphan Drug Congress
  • Exhibitor

    Orphan Reach at World Orphan Drug Congress

    Exhibitor

    Oxford PharmaGenesis at World Orphan Drug Congress
  • Exhibitor

    P.P.D. at World Orphan Drug Congress

    Exhibitor

    PSR-Agility Orphan Drug Development at World Orphan Drug Congress

JOIN THEM

Be part of the conversation

 

MartinaVerolinPresImage

“Harnessing the Power of the Immune System”

Martina Verolin of Toleranzia joined us for World Orphan Drug Congress USA 2015 to present about ‘Harnessing the Power of the Immune System’ . Download the presentation ...

The post “Harnessing the Power of the Immune System” appeared first on Orphan Drugs.

US Market Size Infographic

Infographic: What is the size of the Orphan Drugs Market in the USA?

Here at World Orphan Drug Congress USA, we understand that sometimes it is really useful to have the stats! So here they are – in ...

The post Infographic: What is the size of the Orphan Drugs Market in the USA? appeared first on Orphan Drugs.

“Path to Commercialization: Autologous Neural Stem Cell Therapies for Neurodegenerative Diseases

Teresa Leezer of RhinoCyte, Inc.   joined us for World Orphan Drug Congress USA 2015 to present about ‘ Autologous Neural Stem Cell Therapies for Neurodegenerative Diseases’  Download ...

The post “Path to Commercialization: Autologous Neural Stem Cell Therapies for Neurodegenerative Diseases appeared first on Orphan Drugs.

Join the Community

Strategy and innovation for the orphan drug and rare disease industry

Sign Up to Our Newsletter